Suppr超能文献

皮肤和血清中H1受体拮抗剂的定量分析。

Quantitation of H1-receptor antagonists in skin and serum.

作者信息

Simons F E, Murray H E, Simons K J

机构信息

Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

J Allergy Clin Immunol. 1995 Mar;95(3):759-64. doi: 10.1016/s0091-6749(95)70183-4.

Abstract

BACKGROUND

Cetirizine and hydroxyzine produce prompt, long-lasting peripheral H1-blockade in skin. We hypothesized that after oral administration of these H1-receptor antagonists, skin concentrations would be higher than serum concentrations and would correlate with peripheral H1 blockade.

METHODS

In a randomized, double-blind, parallel-group study in 13 healthy subjects, skin biopsies, venipunctures, and epicutaneous tests with histamine were performed before ingestion of 10 mg cetirizine or 50 mg hydroxyzine and 1, 3, 6, 9, and 24 hours after administration. Subjects then took 10 mg cetirizine or 50 mg hydroxyzine at 21:00 hours for 6 consecutive days. All tests were repeated at 168 hours (steady state), 12 hours after the last dose.

RESULTS

Skin cetirizine concentrations were lower than serum ccetirizine concentrations from 1 to 9 hours but were higher at 24 hours and equivalent at 168 hours (steady state). Skin hydroxyzine concentrations were higher than serum hydroxyzine concentrations at all test times. After hydroxyzine dosing, cetirizine, the active metabolite of hydroxyzine arising in vivo, was found in skin and serum. Single doses of cetirizine or hydroxyzine produced highly significant suppression of wheals and flares from 3 to 24 hours inclusive, and this suppression was maintained at steady state.

CONCLUSIONS

Cetirizine and hydroxyzine enter the skin readily, and their sustained high concentrations in skin after single or multiple dosing may contribute to their well-known efficacy in symptomatic treatment of urticaria and other skin disorders in which histamine plays a role.

摘要

背景

西替利嗪和羟嗪可在皮肤中迅速产生持久的外周H1受体阻滞作用。我们推测,口服这些H1受体拮抗剂后,皮肤中的浓度会高于血清浓度,且与外周H1受体阻滞作用相关。

方法

在一项针对13名健康受试者的随机、双盲、平行组研究中,在摄入10 mg西替利嗪或50 mg羟嗪之前以及给药后1、3、6、9和24小时进行皮肤活检、静脉穿刺以及组胺皮内试验。然后,受试者在21:00时服用10 mg西替利嗪或50 mg羟嗪,连续服用6天。在168小时(稳态)即最后一剂后12小时重复所有测试。

结果

西替利嗪的皮肤浓度在1至9小时低于血清浓度,但在24小时时较高,在168小时(稳态)时相当。羟嗪的皮肤浓度在所有测试时间均高于血清浓度。服用羟嗪后,在皮肤和血清中发现了羟嗪在体内产生的活性代谢产物西替利嗪。单剂量的西替利嗪或羟嗪在3至24小时(含)内对风团和潮红产生了高度显著的抑制作用,且这种抑制作用在稳态时得以维持。

结论

西替利嗪和羟嗪易于进入皮肤,单次或多次给药后它们在皮肤中持续的高浓度可能有助于其在对症治疗荨麻疹和其他组胺起作用的皮肤疾病方面的众所周知的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验